VEGFA and neoplasm: In patients and animal models, the failure of anti-angiogenic therapy based on inhibition of the VEGF pathway is often concomitant with an increase in the number of MDSCs or TAMs infiltrating tumor tissues (Lu-Emerson et al., 2013; Gabrusiewicz et al., 2014).